Kos Biotechnology Partners Announces Investment in Fathom Therapeutics to Advance Novel, AI-Driven Drug Discovery Platform

PR Newswire (AI)November 6, 2026en

PR Newswire (AI)

AI Global Wire

PRNewswire/ -- ("Kos"), a global life sciences investment firm bridging the U.S. and European biopharma ecosystems, today ...

This is a short summary published by AI Global Wire. The full article is owned and hosted by PR Newswire (AI) — open it there to read it in full.